Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information


EU orphan designation number: EU/3/06/414   
Active ingredient: Catumaxomab
Indication: Treatment of gastric cancer
Sponsor: Neovii Biotech GmbH
Am Haag 6-7, 82166 Graefelfing, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
7/11/2006 Orphan designation EMEA/OD/044/06 (2006)5374 of 3/11/2006
24/01/2014 Change of name and/or address of sponsor